[1]
|
Yang, J., Mani, S., Donaher, J., Ramaswamy, S., Itzykson, R., Come, C., Savagner, P., Gitelman, I., Richardson, A. and Weinberg, R.A. (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell, 117, 927-939.
doi:10.1016/j.cell.2004.06.006
|
[2]
|
Puisieux, A., Valsesia-Wittmann, S. and Ansieau, S. (2006) A twist for survival and cancer progression. British Journal of Cancer, 94, 13-17. doi:10.1038/sj.bjc.6602876
|
[3]
|
Vesuna, F., Diest, P., Chen, J.H. and Raman, V. (2008) Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochemical and Biophysical Research Communications, 367, 235-241.
doi:10.1016/j.bbrc.2007.11.151
|
[4]
|
Hamamori, Y., Wu, H.Y., Sartorelli, V. and Kedes, L. (1997) The basic domain of myogenic basic helix-loop-helix (bHLH) Proteins Is the Novel Target for Direct Inhibition by Another bHLH protein, twist. Molecular and Cellular Biology, 17, 6563-6573.
|
[5]
|
Sosic, D. and Olson, E.N. (2003) A new twist on twist: Modulation of the NF-KappaB pathway. Cell Cycle, 2, 76-78. doi:10.4161/cc.2.2.338
|
[6]
|
Cheng, G.Z., Zhang, W.Z., Sun, M., Wang, Q., Coppola, D., Mansour, M., Xu, L.M., Costanzo, C., Cheng, J.Q. and Wang, L.H. (2008) Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function. The Journal of Biological Chemistry, 283, 14665- 14673. doi:10.1074/jbc.M707429200
|
[7]
|
Valdés-Mora, F., Gómez del Pulgar, T., Bandrés, E., Cejas, P., Ramírez, A., Pérez-Palacios, R., Gallego-Ortega, D., García-Cabezas, M.A., Casado, E., Larrauri, J., Nistal, M., González-Barón, M., García-Foncillas, J. and Lacal, J.C. (2009) Twist 1 overexpression is associated with nodal invasion and male sex in primary colorectal cancer. Annals of Surgical Oncology, 16, 78-87.
doi:10.1245/s10434-008-0166-x
|
[8]
|
Maruvada, P. and Srivastava, S. (2004) Biomarkers for cancer diagnosis: Implications for nutritional research. The Journal of Nutrition, 134, 1640S-1645S.
|
[9]
|
Cheng, G.Z., Zhang, W. and Wang, L.H. (2008) Regulation of cancer cell survival, migration, and invasion by Twist: AKT2 comes to interplay. Cancer Research, 68, 957-960. doi:10.1158/0008-5472.CAN-07-5067
|
[10]
|
Shiota, M., Izumi, H., Onitsuka, T., Miyamoto, N., Kashiwagi, E., Kidani, A., Yokomizo, A., Naito, S. and Kohno, K. (2008) Twist promotes tumor cell growth through YB-1 expression. Cancer Research, 68, 98-105.
doi:10.1158/0008-5472.CAN-07-2981
|
[11]
|
Mehrotra, J., Vali, M., McVeigh, M., Kominsky, S.L., Fackler, M.J., Lahti-Domenici, J., Polyak, K., Sacchi, N., Garrett-Mayer, E., Argani, P. and Sukumar, S. (2004) Very high frequency of hypermethylated genes in breast cancer metastasis to the bone, brain, and lung. Clinical Cancer Research, 10, 3104-3109.
doi:10.1158/1078-0432.CCR-03-0118
|
[12]
|
Ciccolini, J., Peillard, L., Aubert, C., Formento, P., Milano, G. and Catalin, J. (2000) Monitoring of the intracellular activation of 5-fluorouracil to deoxyribonucleotides in HT29 human colon cell line: Application to modulation of metabolism and cytotoxicity study. Fundamental and Clinical Pharmacology, 14, 147-154.
doi:10.1111/j.1472-8206.2000.tb00403.x
|
[13]
|
García-Gasca, T., Salazar-Olivo, L.A., Mendiola-Olaya, E. and Blanco-Labra, A. (2002) The effects of a protease inhibitor fraction from tepary bean (Phaseolus acutifolius) on in vitro cell proliferation and cell adhesion of transformed cells. Toxicology in Vitro, 16, 229-233.
doi:10.1016/S0887-2333(02)00006-1
|
[14]
|
Ganguly, S., Ashley, L.A., Pendleton, C.M., Grey, R.D., Howard, G.C., Castle, L.D., Peyton, D.K., Fultz, M.E. and DeMoss, D.L. (2008) Characterization of osteoblastic properties of 7F2 and UMR-106 cultures after acclimation to reduced levels of fetal bovine serum. Canadian Journal of Physiology and Pharmacology, 86, 403-415.
doi:10.1139/Y08-055
|
[15]
|
Lui, K.O., Waldmann, H. and Fairchild, P.J. (2009) Embryonic stem cells: Overcoming the immunological barriers to cell replacement therapy. Current Stem Cell Research and Therapy, 4, 70-80.
doi:10.2174/157488809787169093
|
[16]
|
Zanghi, J.A., Fussenegger, M. and Bailey, J.E. (1999) Serum protects protein-free competent Chinese hamster ovary cells against apoptosis induced by nutrient deprivation in batch culture. Biotechnology and Bioengineering, 64, 108-119.
doi:10.1002/(SICI)1097-0290(19990705)64:1<108::AID-BIT12>3.0.CO;2-B
|
[17]
|
De Castro, M., Orive, G., Gascón, A.R., Hernández, R.M. and Pedraz, J.L. (2006) Evaluation of human serum albumin as a substitute of fetal bovine serum for cell culture. International Journal of Pharmaceutics, 310, 8-14.
doi:10.1016/j.ijpharm.2005.10.028
|
[18]
|
Medina, M.A. (2001) Glutamine and Cancer. The Journal of Nutrition, 131, 2539S-2542S.
|
[19]
|
Pan, Y., Bender, P., Akers, R. and Webb, K. (1998) One or more serum factors promote peptide utilization in cultured animal cells. The Journal of Nutrition, 128, 744- 750.
|
[20]
|
Kamath, S., Conrad, N., Olson, R., Bess, M., Mid, O. and Ghosh, L. (1988) Amino acid-restricted diets in the treatment of mammary adenocarcinoma in mice. The Journal of Nutrition, 118, 1137-1142.
|
[21]
|
Theuer, R.C. (1971) Effect of essential amino acid restriction on the growth of female C57BL mice and their implant BW1023 adenocarcinomas. The Journal of Nutrition, 101, 223-232.
|
[22]
|
Worthington, B., Yrotuck, J. and Ahmed, S. (1978) Effects of essential amino acid deficiencies on syngeneic tumor inmmunity and carcinogenesis in mice. The Journal of Nutrition, 108, 1402-1411.
|
[23]
|
Yen, C., Mar, M., Craciunescu, C., Edwards, L. and Zeisel, S. (2002) Deficiency in methionine, tryptophan, isoleucine, or choline induces apoptosis in cultured cells. The Journal of Nutrition, 132, 1840-1847.
|
[24]
|
Choudry, H.A., Pan, M., Karinch, A.M. and Souba, W.W. (2006) Branched-chain amino acid-enriched nutritional support in surgical and cancer patients. The Journal of Nutrition, 136, 314S-318S.
|
[25]
|
Sawada, K., Noda, K., Nakajima, H., Shimbara, N., Furuichi, Y. and Sugimoto, M. (2005) Differential cytotoxicity of anticancer agents in pre- and post-immortal lym-phoblastoid cell lines. Biological and Pharmaceutical Bulletin, 28, 1202-1207. doi:10.1248/bpb.28.1202
|
[26]
|
Misaki, T., Iwata, M., Iida, Y., Kasagi, K. and Konishi, J. (2002) Chemo-radionuclide therapy for thyroid cancer: Initial experimental study with cultured cells. Annals of Nuclear Medicine, 16, 403-408.
doi:10.1007/BF02990078
|
[27]
|
Brunetti, I., Falcone, A., Calabresi, P., Goulette, F. and Darnowski, J. (1990) 5-Fluorouracil enhances azidothymidine cytotoxicity: in vitro, in vivo, and biochemical studies. Cancer Research, 50, 4026-4031.
|
[28]
|
Tillman, D.M., Petak, I. and Houghton, J.A. (1999) A fas-dependent component in 5-fluorouracil/leucovorin-induced cytotoxicity in colon carcinoma cells. Clinical Cancer Research, 5, 425-430.
|
[29]
|
Hao, N., Whitelaw, M.L., Shearwin, K.E., Dodd, I.B. and Chapman-Smith, A. (2011) Identification of residues in the N-terminal PAS domains important for dimerization of Arnt and AhR. Nucleic Acids Research, 39, 3695- 3709. doi:10.1093/nar/gkq1336
|